Re: Toni K. Choueiri, Piotr Tomczak, Se Hoon Park, et al. Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma. N Engl J Med 2021;385:683–94

Autor:	Alessandro Larcher, Francesco Montorsi, Umberto Capitanio
Rok vydání:	2022
Předmět:	medicine.medical_specialty business.industry Urology medicine.medical_treatment Pembrolizumab medicine.disease Nephrectomy Dissection medicine.anatomical_structure Renal cell carcinoma Medicine business Lymph node Adjuvant
Zdroj:	European Urology. 81:e28
ISSN:	0302-2838
DOI:	10.1016/j.eururo.2021.09.034
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8a5f7eed91621ea47e5766ec8ecf04db https://doi.org/10.1016/j.eururo.2021.09.034 Zobrazit plný text záznamu Full Text from ScienceDirect